Skip to main content
. 2022 Oct 28;7(8):1488–1495. doi: 10.1182/bloodadvances.2022008344

Table 3.

Clinical response at EOI for MRD-negative patients

Clinical response at EOI MRD negative at EOI (N = 13)
IRC assessed, n (%)
 CR 11 (84.6)
 PR 1 (7.7)
 NA 1 (7.7)
Investigator assessed, n (%)
 CR 11 (84.6)
 PR 1 (7.7)
 NA 1 (7.7)

NA, not available.

Assessed according to the modified Lugano 2014 criteria.

Patients were MRD positive at baseline and had repeated testing at EOI; all were negative at EOI.